14-day Premium Trial Subscription Try For FreeTry Free
$0.0541
-0.0045 (-7.68%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0511 $0.0700 Wednesday, 24th Apr 2024 BLPH stock ended at $0.0541. This is 7.68% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 17.21% from a day low at $0.0522 to a day high of $0.0612.
90 days $0.0470 $0.0700
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
Sep 19, 2023 $0.413 $0.413 $0.373 $0.388 74 986
Sep 18, 2023 $0.410 $0.444 $0.410 $0.410 24 073
Sep 15, 2023 $0.437 $0.453 $0.417 $0.417 50 341
Sep 14, 2023 $0.457 $0.459 $0.437 $0.453 19 491
Sep 13, 2023 $0.422 $0.459 $0.422 $0.450 56 519
Sep 12, 2023 $0.415 $0.445 $0.404 $0.445 53 611
Sep 11, 2023 $0.445 $0.447 $0.400 $0.438 63 180
Sep 08, 2023 $0.444 $0.444 $0.430 $0.430 19 941
Sep 07, 2023 $0.441 $0.459 $0.430 $0.450 37 339
Sep 06, 2023 $0.431 $0.459 $0.430 $0.450 44 366
Sep 05, 2023 $0.443 $0.443 $0.425 $0.433 20 488
Sep 01, 2023 $0.439 $0.459 $0.421 $0.436 105 921
Aug 31, 2023 $0.451 $0.470 $0.423 $0.431 121 117
Aug 30, 2023 $0.413 $0.514 $0.391 $0.440 280 104
Aug 29, 2023 $0.403 $0.435 $0.400 $0.426 154 067
Aug 28, 2023 $0.400 $0.405 $0.390 $0.405 62 854
Aug 25, 2023 $0.382 $0.418 $0.377 $0.411 221 509
Aug 24, 2023 $0.390 $0.391 $0.371 $0.382 72 378
Aug 23, 2023 $0.381 $0.394 $0.375 $0.390 64 018
Aug 22, 2023 $0.398 $0.410 $0.370 $0.375 91 078
Aug 21, 2023 $0.385 $0.408 $0.380 $0.406 41 907
Aug 18, 2023 $0.390 $0.420 $0.383 $0.393 106 105
Aug 17, 2023 $0.390 $0.396 $0.373 $0.396 221 779
Aug 16, 2023 $0.393 $0.410 $0.393 $0.393 64 670
Aug 15, 2023 $0.405 $0.415 $0.399 $0.400 114 419
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT